Optruma European Union - English - EMA (European Medicines Agency)

optruma

eli lilly nederland b.v. - raloxifene hydrochloride - osteoporosis, postmenopausal - sex hormones and modulators of the genital system, - optruma is indicated for the treatment and prevention of osteoporosis in post-menopausal women. a significant reduction in the incidence of vertebral, but not hip fractures has been demonstrated. when determining the choice of optruma or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefits (see section 5.1).

Raloxifene Teva European Union - English - EMA (European Medicines Agency)

raloxifene teva

teva b.v. - raloxifene hydrochloride - osteoporosis, postmenopausal - sex hormones and modulators of the genital system, - raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women. a significant reduction in the incidence of vertebral, but not hip fractures has been demonstrated.when determining the choice of raloxifene or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefits.

Raloxifene Hydrochloride 60mg film-coated Tablets Malta - English - Medicines Authority

raloxifene hydrochloride 60mg film-coated tablets

brillpharma (ireland) limited inniscarra, main street, rathcoole, co. dublin, ireland - raloxifene hydrochloride - film-coated tablet - raloxifene hydrochloride 60 mg - sex hormones and modulators of the genital system